Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
0.1363
+0.0126 (10.19%)
At close: Apr 10, 2026, 4:00 PM EDT
0.1186
-0.0177 (-12.99%)
After-hours: Apr 10, 2026, 7:49 PM EDT
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $7.59 million as of April 10, 2026. Its market cap has decreased by -87.13% in one year.
Market Cap
7.59M
Enterprise Value
8.19M
1-Year Change
-87.13%
Ranking
Category
Stock Price
$0.14
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.58M to $7.59M, a decrease of -99.11%. That is a compound annual growth rate of -49.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 7.59M | -95.93% |
| Dec 31, 2025 | 186.53M | 126.70% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Processa Pharmaceuticals | 7.63M |
| TransCode Therapeutics | 7.57M |
| GridAI Technologies | 7.43M |
| BioAtla | 7.42M |
| PharmaCyte Biotech | 7.41M |
| Xenetic Biosciences | 7.22M |
| Alaunos Therapeutics | 7.13M |
| Acurx Pharmaceuticals | 7.05M |